Dr. Shore Discusses NEJM Studies in Video SeriesAug. 2020 Neal Shore, MD, FACS, Medical Director for the Carolina Urologic Research Center and Past-President of LUGPA, has led an extensive amount of research in the treatment and management of prostate cancer. In a series of interviews with Oncology Tube, Dr. Shore talks about the recent NEJM Studies (Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer, Olaparib for Metastatic Castration-Resistant Prostate Cancer, and Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer):
|
Announcements
A Survey of Patient Understanding of Muscle Invasive Bladder Cancer Treatment
Now Enrolling!
Learn How You Can Refer Patients
Join the Women’s Urologic Health Alliance
Subscribe to be a part of the discussion, receive WUHA news and announcements.
Learn how to have your facility become a SRC/NAFC Center of Excellence In Continence Care for Women. LUGPA groups will receive a discount on certification fees.
LUGPA members can login to access past content On Demand.